<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833214/" ref="ordinalpos=1956&amp;ncbi_uid=2737391&amp;link_uid=PMC2833214" image-link="/pmc/articles/PMC2833214/figure/F2/" class="imagepopup">FIGURE 2. Myogenic <span class="highlight" style="background-color:">signaling</span> in pathogenesis of muscular dystrophy.  From: Therapeutic Targeting of <span class="highlight" style="background-color:">Signaling</span> Pathways in Muscular Dystrophy. </a></div><br /><div class="p4l_captionBody">A number of intrinsic and/or extrinsic stimuli lead to the activation of specific cell signaling pathways in skeletal muscle in muscular dystrophy. Depending on the type of muscular dystrophy, activation of a specific pathway may ameliorate or exacerbate disease progression. Red: exaggeration in pathogenesis; green: amelioration of pathogenesis; yellow: role not yet known. Cn, Calcineurin; DMD, Duchenne muscular dystrophy; EMD, Emery-Dreifuss muscular dystrophy; LGMD, Limb girdle muscular dystrophy.</div></div>